HealthEquityFRA:2HE -0.65%92 Current Ratio is 3.44 as of Apr. 2026, which is 18% below its 10-year median of 4.18. GuruFocus rates FRA:2HE with a GF Score™ of 92/100 and a GF Value™ of €87.33. The stock has 1 warning sign investors should review. Among 681 Healthcare Providers & Services companies, HealthEquity ranks better than 81.35% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. HealthEquity's current ratio for the quarter that ended in Apr. 2026 was 3.44.
HealthEquity has a current ratio of 3.44. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for HealthEquity's Current Ratio or its related term are showing as below:
FRA:2HE'
s Current Ratio Range Over the Past 10 Years
Min: 1.91 Med: 4.18 Max: 22.98
Current: 3.44
During the past 13 years, HealthEquity's highest Current Ratio was 22.98. The lowest was 1.91. And the median was 4.18.
FRA:2HE's Current Ratio is ranked better than 81.35% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs FRA:2HE: 3.44
HealthEquity (FRA:2HE) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
HealthEquity Current Ratio Related Terms
HealthEquity Current Ratio Historical Data
* Premium members only.
The historical data trend for HealthEquity's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2HE vs HNGE, TEM, TXG: Current Ratio Comparison
For the Health Information Services subindustry, HealthEquity's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Current Ratio distribution charts can be found below:
* The bar in red indicates where HealthEquity's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity (FRA:2HE) has a Current Ratio of 3.44 as of Apr. 2026. This is 18% below median its historical median of 4.18. Over the past decade, HealthEquity's Current Ratio has ranged from 1.91 to 22.98. According to the industry distribution chart, HealthEquity ranks #127 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 18.6%.
Is HealthEquity's Current Ratio too high?
HealthEquity's current Current Ratio of 3.44 is 18% below median its 10-year median of 4.18. Over the past 10 years, this metric has ranged from a low of 1.91 to a high of 22.98. The Healthcare Providers & Services industry median Current Ratio is 1.47. HealthEquity's value of 3.44 is 134% above this industry median. Based on the distribution chart, HealthEquity ranks #127 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, HealthEquity has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Current Ratio compare to HNGE and TEM?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #127 out of 681 companies for Current Ratio. This places HealthEquity in the top 19% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. HealthEquity's value of 3.44 is 134% above this benchmark. Historically, HealthEquity's own Current Ratio has ranged from 1.91 to 22.98 over the past decade. While the company's 10-year median is 4.18 vs. the industry median of 1.47, HealthEquity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current Current Ratio of 3.44 is 134% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current Current Ratio is 3.44, which is 18% below median its own 10-year median of 4.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Current Ratio of 3.44. The stock's GF Value™ is €87.33, compared to a current price of €76.50 — trading 12.4% below its estimated fair value. The current Current Ratio is 3.44, which is 18% below median its 10-year median of 4.18 and 134% above the Healthcare Providers & Services industry median of 1.47. HealthEquity's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Current Ratio is 3.44 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (FRA:2HE) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued.
The current stock price of €76.50 is trading 12.4% below its estimated GF Value™ of €87.33.
Key valuation signals for FRA:2HE:
Current Ratio: 3.44 (18% below median its 10-year median of 4.18)
GF Value™: €87.33 vs. price of €76.50 (12.4% below fair value)
Industry Position: 134% above the Healthcare Providers & Services median (#127 of 681)
No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
92GF Score
Get the complete analysis for FRA:2HE
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2HE has been successfully added to your 
